DUBLIN, April 11, 2023 /PRNewswire/ -- The "Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global biomarker technologies market size reached US$ 31.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 67.7 Billion by 2027, exhibiting a CAGR of 13.84% during 2021-2027.
Companies Mentioned
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Illumina Inc.
- LI-COR Inc.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN N.V.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders.
They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.
There is currently a considerable rise in the number of individuals who are suffering from cancer and cardiovascular, neurological, and autoimmune diseases across the globe. This, coupled with the escalating demand for early and effective diagnosis, represents one of the key factors positively influencing the market. Apart from this, the rising geriatric population is also contributing to the growth of the market.
Moreover, there is an increase in research and development (R&D) funding for drug discovery by governing agencies of numerous countries. This, along with the considerably expanding healthcare infrastructure, especially in developing countries, is propelling the market growth.
Furthermore, leading market players are introducing numerous advancements in biomarker technologies that provide accurate patient stratification. They are also developing digital biomarkers that aid in collecting objective, quantifiable, physiological, and behavioral data by using digital devices.
These digital biomarkers are also incorporated with artificial intelligence (AI), machine learning (ML) solutions for big data analysis, and integrated decision making. Other major factors, including rising awareness about the early detection of cancer for better treatment, and surging income levels of individuals, are projected to impel the market growth.
Key Questions Answered in This Report:
- How has the global biomarker technologies market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global biomarker technologies market?
- What are the key regional markets?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global biomarker technologies market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biomarker Technologies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test Type
6.1 Solid Biopsy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Liquid Biopsy
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Indication
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Infectious Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autoimmune Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular Disorders
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Product
8.1 Consumables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Assay
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Reagent
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Instruments
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Technology
9.1 Polymerase Chain Reaction (PCR)
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Next Generation Sequencing (NGS)
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Immunoassay
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Application
10.1 Drug Discovery
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinical Diagnostics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Personalized Medicine
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
12 SWOT Analysis
13 Value Chain Analysis
14 Porters Five Forces Analysis
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/bpal5w
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
Share this article